Cell

Diagnostic & Therapeutic Technologies

The functional integration of man-made devices and biological systems represents one of the grand challenges of science and technology, and the development of diagnostic and therapeutic technologies, including Nanomedicine, will be crucial over the next twenty years in delivering improved healthcare and patient management.

The work of Diagnostic and Therapeutic Technologies lies at the heart of modern medical engineering and care provision. We work at the interface between nano-, bio-, micro- and genomic engineering technologies to develop new systems and device technologies, and apply these new technologies in areas of real medical need in order to improve patient care and management.

The ICM Diagnostic and Therapeutic Technologies group forms the core of a University-wide venture combining expertise across faculties, to create impact through highly adventurous interdisciplinary research into sensor systems. Diagnostic and Therapeutic Technologies currently collaborate with the Institute for Cell and Molecular Biosciences, the Centre for Bacterial Cell Biology, the Centre for Synthetic Biology, the School of Computer Science, the School of Mechanical and Systems Engineering, and the Institute for Ageing and Health. The group also work with academic and industrial scientists from across Europe on large scale collaborative research initiatives. These developments are undertaken in partnership with clinicians at the Newcastle Healthcare NHS Foundation Trust, the Health Protection Agency, and with the UK medical devices industry.

Key Research themes

  • Biosensor systems for rapid clinical diagnostics
  • Microelectromechanical systems for biological sensing (BioMEMS)
  • Graphene based nanomaterials for sensing platforms
  • Cell-chip technologies for real-time, high content, intra- and extra-cellular measurements

Selected Projects

Further information